Tu Diep
Chief Development Officer at Skye Bioscience Inc. | San Diego, California, United States
Tu Diep’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Chief Development Officer at Skye Bioscience Inc. in January 2022 - Present
Senior Vice President Development at Skye Bioscience Inc. in January 2021 - August 2023
Director Business Process at Element Biosciences in April 2020 - October 2020
Vice President Strategic Operations at Emerald Health USA, Inc. in July 2018 - April 2020
SVP, Head of Operations at OncoSec in October 2017 - July 2018
Vice President Operations at OncoSec in September 2014 - July 2018
Executive Director, Clinical Development at OncoSec in April 2013 - September 2014
Director, Clinical Operations at OncoSec in February 2011 - April 2013
Manager, Business Development and Operations at Protox Therapeutics in January 2007 - March 2011
Skye Bioscience (Nasdaq: SKYE) is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye plans to start a Phase 2 clinical trial in obesity in Q3 2024 for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1, comparing monotherapy and combination arms of nimacimab and a GLP-1R agonist (Wegovy®).
Discover more about Skye Bioscience Inc.
People Ops & Talent
I own all talent and people operations
President & CEO at Skye Bioscience, Inc.
Skye is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye is conducting a Phase 2 clinical trial (ClinicalTrials.gov: NCT06577090) in obesity for nimacimab, a ...
Biopharmaceutical CMC & Tech Ops Executive
Senior Vice President & Head of CMC at Skye Bioscience Inc.
(Jul 2025 – Present)
Senior Director of Clinical Operations | Owning Phase II–III Assets in Ophthalmology & Metabolic Disease | Biotech Sponsor Leader
Senior Director Clinical Operations at Skye Bioscience Inc.
(May 2024 – Present)
Drug Development & Program Management Leader | Discovery-to-Clinical Development | Regulatory Strategy | CMC | IND/NDA Execution | Obesity, Cancer, Immunology & Rare Disease
Associate Director of Program Management at Skye Bioscience Inc.
(Jun 2025 – Present)
Accounting & Finance
Controller at Skye Bioscience Inc.
(May 2025 – Present)
What is Tu Diep email address?
Email Tu Diep at [email protected]. This email is the most updated Tu Diep's email found in 2026.
How to contact Tu Diep?
To contact Tu Diep send an email to [email protected].
What company does Tu Diep work for?
Tu Diep works for Skye Bioscience Inc..
What is Tu Diep's role at Skye Bioscience Inc.?
Tu Diep is Chief Development Officer
What industry does Tu Diep work in?
Tu Diep works in the Biotechnology industry.
